935 related articles for article (PubMed ID: 29437599)
1. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
2. Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).
Seliger SL; de Lemos J; Neeland IJ; Christenson R; Gottdiener J; Drazner MH; Berry J; Sorkin J; deFilippi C
JACC Heart Fail; 2015 Jun; 3(6):445-455. PubMed ID: 25982111
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.
Neeland IJ; Drazner MH; Berry JD; Ayers CR; deFilippi C; Seliger SL; Nambi V; McGuire DK; Omland T; de Lemos JA
J Am Coll Cardiol; 2013 Jan; 61(2):187-95. PubMed ID: 23219305
[TBL] [Abstract][Full Text] [Related]
4. Increased Myocardial Stiffness in Patients With High-Risk Left Ventricular Hypertrophy: The Hallmark of Stage-B Heart Failure With Preserved Ejection Fraction.
Hieda M; Sarma S; Hearon CM; Dias KA; Martinez J; Samels M; Everding B; Palmer D; Livingston S; Morris M; Howden E; Levine BD
Circulation; 2020 Jan; 141(2):115-123. PubMed ID: 31865771
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure.
Wang Y; Yang H; Huynh Q; Nolan M; Negishi K; Marwick TH
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1390-1400. PubMed ID: 29778859
[TBL] [Abstract][Full Text] [Related]
6. Novel Index of Maladaptive Myocardial Remodeling in Hypertension.
Goh VJ; Le TT; Bryant J; Wong JI; Su B; Lee CH; Pua CJ; Sim CPY; Ang B; Aw TC; Cook SA; Chin CWL
Circ Cardiovasc Imaging; 2017 Sep; 10(9):e006840. PubMed ID: 28847911
[TBL] [Abstract][Full Text] [Related]
7. Regional diastolic dysfunction in individuals with left ventricular hypertrophy measured by tagged magnetic resonance imaging--the Multi-Ethnic Study of Atherosclerosis (MESA).
Edvardsen T; Rosen BD; Pan L; Jerosch-Herold M; Lai S; Hundley WG; Sinha S; Kronmal RA; Bluemke DA; Lima JA
Am Heart J; 2006 Jan; 151(1):109-14. PubMed ID: 16368301
[TBL] [Abstract][Full Text] [Related]
8. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.
Lewis AA; Ayers CR; Selvin E; Neeland I; Ballantyne CM; Nambi V; Pandey A; Powell-Wiley TM; Drazner MH; Carnethon MR; Berry JD; Seliger SL; DeFilippi CR; de Lemos JA
Circulation; 2020 Mar; 141(12):957-967. PubMed ID: 31931608
[TBL] [Abstract][Full Text] [Related]
9. Association of a 4-Tiered Classification of LV Hypertrophy With Adverse CV Outcomes in the General Population.
Garg S; de Lemos JA; Ayers C; Khouri MG; Pandey A; Berry JD; Peshock RM; Drazner MH
JACC Cardiovasc Imaging; 2015 Sep; 8(9):1034-1041. PubMed ID: 26298074
[TBL] [Abstract][Full Text] [Related]
10. Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
Xanthakis V; Larson MG; Wollert KC; Aragam J; Cheng S; Ho J; Coglianese E; Levy D; Colucci WS; Michael Felker G; Benjamin EJ; Januzzi JL; Wang TJ; Vasan RS
J Am Heart Assoc; 2013 Nov; 2(6):e000399. PubMed ID: 24200688
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of Atherosclerosis.
Choi EY; Bahrami H; Wu CO; Greenland P; Cushman M; Daniels LB; Almeida AL; Yoneyama K; Opdahl A; Jain A; Criqui MH; Siscovick D; Darwin C; Maisel A; Bluemke DA; Lima JA
Circ Heart Fail; 2012 Nov; 5(6):727-34. PubMed ID: 23032197
[TBL] [Abstract][Full Text] [Related]
12. Kansas City Cardiomyopathy Questionnaire Score Is Associated With Incident Heart Failure Hospitalization in Patients With Chronic Kidney Disease Without Previously Diagnosed Heart Failure: Chronic Renal Insufficiency Cohort Study.
Mishra RK; Yang W; Roy J; Anderson AH; Bansal N; Chen J; DeFilippi C; Delafontaine P; Feldman HI; Kallem R; Kusek JW; Lora CM; Rosas SE; Go AS; Shlipak MG;
Circ Heart Fail; 2015 Jul; 8(4):702-8. PubMed ID: 25985796
[TBL] [Abstract][Full Text] [Related]
13. Long-term trajectory of two unique cardiac biomarkers and subsequent left ventricular structural pathology and risk of incident heart failure in community-dwelling older adults at low baseline risk.
Glick D; deFilippi CR; Christenson R; Gottdiener JS; Seliger SL
JACC Heart Fail; 2013 Aug; 1(4):353-360. PubMed ID: 24621939
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular hypertrophy phenotype to predict incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.
Wang L; Yi J; Zhou Z; Liu J; Li Y; Tian A; Ren X; Zheng X
Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1399-1406. PubMed ID: 38402001
[TBL] [Abstract][Full Text] [Related]
15. Association between long-term prescription of febuxostat and the progression of heart failure with preserved ejection fraction in patients with hypertension and asymptomatic hyperuricemia.
Pan JA; Lin H; Wang CQ; Zhang JF; Gu J
Heart Vessels; 2020 Oct; 35(10):1446-1453. PubMed ID: 32430700
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
[TBL] [Abstract][Full Text] [Related]
17. Addition of highly sensitive troponin T and N-terminal pro-B-type natriuretic peptide to electrocardiography for detection of left ventricular hypertrophy: results from the Dallas Heart Study.
Martinez-Rumayor AA; de Lemos JA; Rohatgi AK; Ayers CR; Powell-Wiley TM; Lakoski SG; Berry JD; Khera A; Das SR
Hypertension; 2013 Jan; 61(1):105-11. PubMed ID: 23150502
[TBL] [Abstract][Full Text] [Related]
18. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Atherosclerosis, Cardiac and Kidney Function, Heart Failure, and Dementia in the Very Elderly.
Kuller LH; Lopez OL; Gottdiener JS; Kitzman DW; Becker JT; Chang Y; Newman AB
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735291
[TBL] [Abstract][Full Text] [Related]
20. Left ventricular ejection fraction assessment in older adults: an adjunct to natriuretic peptide testing to identify risk of new-onset heart failure and cardiovascular death?
deFilippi CR; Christenson RH; Kop WJ; Gottdiener JS; Zhan M; Seliger SL
J Am Coll Cardiol; 2011 Sep; 58(14):1497-506. PubMed ID: 21939835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
